The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Active-learning strategies in computer-assisted drug discovery
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2009) · Minds at UW (University of Wisconsin) · Cited by 4,791
ChEMBL: a large-scale bioactivity database for drug discovery
Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr777 · Cited by 4,382
Hawkey, C. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12154-2 · Cited by 1,173
Integration of virtual and high-throughput screening
Bajorath, J. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd941 · Cited by 930
Automated design of ligands to polypharmacological profiles
Besnard, J., Ruda, G. F., Setola, V., Abecassis, K., Rodriguiz, R. M., Huang, X.-P., Norval, S., Sassano, M. F., Shin, A. I., Webster, L. A., et al. (2012) · Nature · doi:10.1038/nature11691 · Cited by 832
Global mapping of pharmacological space
Paolini, G. V., Shapland, R. H. B., van Hoorn, W. P., Mason, J. S., & Hopkins, A. L. (2006) · Nature Biotechnology · doi:10.1038/nbt1228 · Cited by 811
Targeting the cancer kinome through polypharmacology
Knight, Z. A., Lin, H., & Shokat, K. M. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2787 · Cited by 674
Functional genomic hypothesis generation and experimentation by a robot scientist
King, R. D., Whelan, K. E., Jones, F. M., Reiser, P. G. K., Bryant, C. H., Muggleton, S. H., Kell, D. B., & Oliver, S. G. (2004) · Nature · doi:10.1038/nature02236 · Cited by 662
Scheffer, T. (2005) · Encyclopedia of Data Warehousing and Mining · doi:10.4018/978-1-59140-557-3.ch192 · Cited by 624
Shifting from the single to the multitarget paradigm in drug discovery
Medina-Franco, J. L., Giulianotti, M. A., Welmaker, G. S., & Houghten, R. A. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.01.008 · Cited by 483
Cited by
Deep reinforcement learning for de novo drug design
Popova, M., Isayev, O., & Tropsha, A. (2018) · Science Advances · doi:10.1126/sciadv.aap7885 · Cited by 1,182
Bayesian reaction optimization as a tool for chemical synthesis
Shields, B. J., Stevens, J., Li, J., Parasram, M., Damani, F., Alvarado, J. I. M., Janey, J. M., Adams, R. P., & Doyle, A. G. (2021) · Nature · doi:10.1038/s41586-021-03213-y · Cited by 1,063
Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery
Yang, X., Wang, Y., Byrne, R., Schneider, G., & Yang, S. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00728 · Cited by 1,022
Self-citationSchneider, G. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.232 · Cited by 910
Self-citationCombining Machine Learning and Computational Chemistry for Predictive Insights Into Chemical Systems
Keith, J. A., Vassilev-Galindo, V., Cheng, B., Chmiela, S., Gastegger, M., Müller, K.-R., & Tkatchenko, A. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00107 · Cited by 849
Less is more: Sampling chemical space with active learning
Smith, J. S., Nebgen, B., Lubbers, N., Isayev, O., & Roitberg, A. E. (2018) · The Journal of Chemical Physics · doi:10.1063/1.5023802 · Cited by 811
Therapeutic Potential of Spirooxindoles as Antiviral Agents
Ye, N., Chen, H., Wold, E. A., Shi, P.-Y., & Zhou, J. (2016) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.6b00041 · Cited by 493
Artificial intelligence in drug discovery: recent advances and future perspectives
Jiménez-Luna, J., Grisoni, F., Weskamp, N., & Schneider, G. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1909567 · Cited by 464
Self-citationTransfer Learning for Drug Discovery
Cai, C., Wang, S., Xu, Y., Zhang, W., Tang, K., Ouyang, Q., Lai, L., & Pei, J. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b02147 · Cited by 366
Autonomous Discovery in the Chemical Sciences Part I: Progress
Coley, C. W., Eyke, N. S., & Jensen, K. F. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201909987 · Cited by 317
COMBO: An efficient Bayesian optimization library for materials science
Ueno, T., Rhone, T. D., Hou, Z., Mizoguchi, T., & Tsuda, K. (2016) · Materials Discovery · doi:10.1016/j.md.2016.04.001 · Cited by 309
Synthetic organic chemistry driven by artificial intelligence
de Almeida, A. F., Moreira, R., & Rodrigues, T. (2019) · Nature Reviews Chemistry · doi:10.1038/s41570-019-0124-0 · Cited by 303
Smith, J. S., Zubatyuk, R., Nebgen, B., Lubbers, N., Barros, K., Roitberg, A. E., Isayev, O., & Tretiak, S. (2020) · Scientific Data · doi:10.1038/s41597-020-0473-z · Cited by 280
Visan, A. I., & Negut, I. (2024) · Life · doi:10.3390/life14020233 · Cited by 279
Use of machine learning approaches for novel drug discovery
Lima, A. N., Philot, E. A., Trossini, G. H. G., Scott, L. P. B., Maltarollo, V. G., & Honorio, K. M. (2016) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2016.1146250 · Cited by 254
Combining generative artificial intelligence and on-chip synthesis for de novo drug design
Grisoni, F., Huisman, B. J. H., Button, A. L., Moret, M., Atz, K., Merk, D., & Schneider, G. (2021) · Science Advances · doi:10.1126/sciadv.abg3338 · Cited by 190
Self-citationArtificial intelligence in chemistry and drug design
Brown, N., Ertl, P., Lewis, R., Luksch, T., Reker, D., & Schneider, N. (2020) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-020-00317-x · Cited by 165
Self-citationThe machine learning life cycle and the cloud: implications for drug discovery
Spjuth, O., Frid, J., & Hellander, A. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1932812 · Cited by 67
Deep learning for low-data drug discovery: Hurdles and opportunities
van Tilborg, D., Brinkmann, H., Criscuolo, E., Rossen, L., Özçelik, R., & Grisoni, F. (2024) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2024.102818 · Cited by 61
Niazi, S. K. (2025) · Pharmaceuticals · doi:10.3390/ph18091271 · Cited by 61
“Key advances in deep generative models [30,31], diffusion models [32], active learning strategies [33], multi-objective optimization [34], and agentic AI systems [35] have demonstrated significant potential to enhance pharmaceutical research and development when used in conjunction with traditional…”
Metadata
- Authors
- Reker, D., & Schneider, G.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2015-04
- Volume
- 20
- Issue
- 4
- Pages
- 458-465
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W1991238353
- Cited by
- 261
- References
- 51
- FWCI
- 7.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.